New Zealand Liver Transplant Unit, Auckland City Hospital, Auckland 1023, New Zealand.
J Virol. 2010 Jan;84(1):621-9. doi: 10.1128/JVI.01471-09.
The full repertoire of hepatitis B virus (HBV) peptides that bind to the common HLA class I molecules found in areas with a high prevalence of chronic HBV infection has not been determined. This information may be useful for designing immunotherapies for chronic hepatitis B. We identified amino acid residues under positive selection pressure in the HBV core gene by phylogenetic analysis of cloned DNA sequences obtained from HBV DNA extracted from the sera of Tongan subjects with inactive, HBeAg-negative chronic HBV infections. The repertoires of positively selected sites in groups of subjects who were homozygous for either HLA-B4001 (n = 10) or HLA-B5602 (n = 7) were compared. We identified 13 amino acid sites under positive selection pressure. A significant association between an HLA class I allele and the presence of nonsynonymous mutations was found at five of these sites. HLA-B4001 was associated with mutations at E77 (P = 0.05) and E113 (P = 0.002), and HLA-B5602 was associated with mutations at S21 (P = 0.02). In addition, amino acid mutations at V13 (P = 0.03) and E14 (P = 0.01) were more common in the seven subjects with an HLA-A*02 allele. In summary, we have developed an assay that can identify associations between HLA class I alleles and HBV core gene amino acids that mutate in response to selection pressure. This is consistent with published evidence that CD8(+) T cells have a role in suppressing viral replication in inactive, HBeAg-negative chronic HBV infection. This assay may be useful for identifying the clinically significant HBV peptides that bind to common HLA class I molecules.
乙型肝炎病毒 (HBV) 与在慢性 HBV 感染高发地区发现的常见 HLA Ⅰ类分子结合的完整肽库尚未确定。这些信息可能对设计慢性乙型肝炎的免疫疗法有用。我们通过对从具有非活动、HBeAg 阴性慢性 HBV 感染的汤加受试者血清中提取的 HBV DNA 克隆 DNA 序列进行系统发育分析,确定了 HBV 核心基因中受正选择压力影响的氨基酸残基。我们比较了两组受试者中受正选择压力影响的阳性选择位点的谱,这两组受试者分别为 HLA-B4001(n = 10)或 HLA-B5602(n = 7)纯合子。我们确定了 13 个受正选择压力影响的氨基酸位点。在其中 5 个位点发现了 HLA Ⅰ类等位基因与非同义突变存在的显著相关性。HLA-B4001 与 E77(P = 0.05)和 E113(P = 0.002)的突变相关,而 HLA-B5602 与 S21(P = 0.02)的突变相关。此外,在 7 名 HLA-A*02 等位基因受试者中,V13(P = 0.03)和 E14(P = 0.01)的氨基酸突变更为常见。总之,我们已经开发了一种可以鉴定 HLA Ⅰ类等位基因与 HBV 核心基因氨基酸之间关联的检测方法,这些氨基酸会因受到选择压力而发生突变。这与已发表的证据一致,即 CD8(+) T 细胞在抑制非活动、HBeAg 阴性慢性 HBV 感染中的病毒复制方面发挥作用。该检测方法可能有助于鉴定与常见 HLA Ⅰ类分子结合的具有临床意义的 HBV 肽。